Clinical Trial Update: A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM). [Phase 2, Phase 3]

View source ↗

Summary

Cytokinetics is conducting a Phase 2/3 clinical trial to evaluate aficamten in pediatric patients with symptomatic obstructive hypertrophic cardiomyopathy, and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Drugs mentioned

• Aficamten (aficamten)

Snippet

Sponsor: Cytokinetics | Conditions: Pediatric, Symptomatic Obstructive Hypertrophic Cardiomyopathy | Phase 2, Phase 3 | Status: RECRUITING